(Applause) The data that we presented to FDA from 107 people in our pilot studies, including Tony, showed that 23 percent of the people that received therapy without active MDMA no longer had PTSD at the end of treatment.
(Pljesak) Podaci koje smo iznijeli pred FDA uključuju 107 ljudi iz naše pilot studije, zajedno s Tonyjem, i pokazuju da je u kontrolnoj grupi bilo 23 posto ljudi izliječenih od PTSP-a na samom kraju tretmana.